Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
317.4 INR | +1.89% | +0.68% | -19.51% |
05-22 | Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules | MT |
05-16 | Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+32.04% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.30% | 205B | |
-5.40% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- INDOCO Stock
- INDOCO Stock
- News Indoco Remedies Limited
- Transcript : Indoco Remedies Limited, Q2 2022 Earnings Call, Nov 02, 2021